Sullivan Christopher Ryan
Chief Financial Officer
CIK: 1810417
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Avalo Therapeutics, Inc. (AVTX) | M | 31,031 | $0.00 | $0.00 | View Details Filing |
| Aug 18, 2026 | Avalo Therapeutics, Inc. (AVTX) | M | 31,031 | $9.88 | $306,586.28 | View Details Filing |
| Aug 18, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 31,031 | $20.05 | $622,323.60 | View Details Filing |
| Aug 17, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 37,945 | $19.85 | $753,333.47 | View Details Filing |
| Aug 17, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 3,749 | $19.94 | $74,762.18 | View Details Filing |
| Aug 17, 2026 | Avalo Therapeutics, Inc. (AVTX) | M | 2,876 | $0.00 | $0.00 | View Details Filing |
| Aug 17, 2026 | Avalo Therapeutics, Inc. (AVTX) | M | 37,945 | $0.00 | $0.00 | View Details Filing |
| Aug 17, 2026 | Avalo Therapeutics, Inc. (AVTX) | M | 37,945 | $9.88 | $374,896.60 | View Details Filing |
| Aug 17, 2026 | Avalo Therapeutics, Inc. (AVTX) | M | 2,876 | $9.88 | $28,414.88 | View Details Filing |
| Jun 10, 2026 | Avalo Therapeutics, Inc. (AVTX) | F | 138 | $13.10 | $1,807.80 | View Details Filing |
22 more transactions available โ create a free account to see 12 months of history | ||||||